product summary
Loading...
company name :
MyBioSource
product type :
other
product name :
DHODH Antibody
catalog :
MBS8502984
quantity :
0.1 mg
price :
300 USD
more info or order :
MyBioSource product webpage
image
image 1 :
MyBioSource MBS8502984 image 1
Immunohistochemistry analysis of paraffin-embedded human lung carcinoma tissue, using DHODH
image 2 :
MyBioSource MBS8502984 image 2
Western Blot analysis of extracts from Jurkat cells, using DHODH antibody
product information
catalog number :
MBS8502984
products type :
Antibody
products full name :
DHODH Antibody
products short name :
[DHODH]
other names :
[dihydroorotate dehydrogenase (quinone), mitochondrial; Dihydroorotate dehydrogenase (quinone), mitochondrial; dihydroorotate dehydrogenase (quinone), mitochondrial; dihydroorotate dehydrogenase (quinone); Dihydroorotate oxidase]
products gene name :
[DHODH]
other gene names :
[DHODH; DHODH; URA1; POADS; DHOdehase; DHOdehase]
sequence length :
395
image1 heading :
Immunohistochemistry
image2 heading :
Western Blot
ncbi gi num :
45006951
ncbi acc num :
NP_001352.2
ncbi gb acc num :
NM_001361.4
uniprot acc num :
Q02127
ncbi mol weight :
42,867 Da
ncbi pathways :
Metabolism Pathway (477135); Metabolism Of Nucleotides Pathway (106263); Pyrimidine Biosynthesis Pathway (161056); Pyrimidine Metabolism Pathway (106281); Pyrimidine Metabolism Pathway (82946); Pyrimidine Metabolism Pathway (309); Uridine Monophosphate Biosynthesis, Glutamine (+ PRPP) = UMP Pathway (524498); Uridine Monophosphate Biosynthesis, Glutamine (+ PRPP) = UMP Pathway (468244)
ncbi summary :
The protein encoded by this gene catalyzes the fourth enzymatic step, the ubiquinone-mediated oxidation of dihydroorotate to orotate, in de novo pyrimidine biosynthesis. This protein is a mitochondrial protein located on the outer surface of the inner mitochondrial membrane. [provided by RefSeq, Jul 2008]
uniprot summary :
Catalyzes the conversion of dihydroorotate to orotate with quinone as electron acceptor.MiscellaneousThe identification of DHODH defects as the cause of postaxial acrofacial dysostosis (POADS) was obtained via exome sequencing (PubMed:19915526), demonstrating that this method is a powerful tool for identifying genes underlying rare Mendelian disorders. Exome sequencing consists of targeted resequencing of all protein-coding subsequences, which requires around 5% as much sequencing as a whole human genome.
size1 :
0.1 mg
price1 :
300 USD
more info or order :
MyBioSource product webpage
company information
MyBioSource
P.O. Box 153308
San Diego, CA 92195-3308
sales@mybiosource.com
https://www.mybiosource.com
1-888-627-0165
headquarters: USA
MyBioSource, LLC was orginally founded in Vancouver by three enthusiastic scientists who are passionate about providing the world with the best reagents available. Together, they form a company with a big vision known as MyBioSource. MyBioSource is now located in San Diego, California, USA.

"MyBioSource's number 1 vision is to be the world's number 1 quality reagents provider."

Our goal is to provide researchers, scientists and customers alike with a one-stop-shop for all of their reagents needs, whether it is monoclonal antibody, polyclonal antibody, recombinant protein, peptide, etc...

"MyBioSource offers the best products at unbeatable prices."

Please spend a few minutes to browse our online catalogs and see the wide range of products available. We ship our products through our shipping/distribution facility in San Diego, California, USA.

Would you like to receive email and e-newsletter from MyBioSource about new products, special offers and events? Please click here to join our Mailing List!